Mandate

Vinge advises Industrifonden in connection with investment in Smartfish

September 18, 2013

Industrifonden is investing SEK 35 million in the Norwegian company, Smartfish, which develops Omega 3 drinks within the field of clinical nutrition. The current owner, Investinor and private investors are also participating in the new issue valued at approximately SEK 80 million. The money will primarily be used for clinical trials and future international expansion. Smartfish develops prescription-based Omega 3-enriched drinks in the form of fruit juice for, e.g. cancer patients, who often develop cachexia, i.e. emaciation caused by significant, long-term malnourishment. At the same time, a new product for Alzheimer patients is being developed. The company holds a patented method which makes it possible to introduce high doses of Omega 3 fatty acid into the juice without affecting its taste.

Smartfish is headquartered in Oslo, although production occurs in Sweden. The company has recently been awarded a procurement contract pertaining to clinical nutrition in Skåne, which will be launched in Sweden this autumn. As a result of the capital infusion, an R&D centre will be established in Stockholm.

The investment in Starfish is the first stage of a recently commenced life science co-operation between Industrifonden and the Norwegian investment enterprise, Investinor. The aim is to give attractive life science companies access to international capital.

Vinge’s team consisted of partner Johan Larsson and associate Alexandra Kempe.   

Related

Vinge advises The Qt Company Ltd on its public offer for I.A.R. Systems Group AB (publ)

The Qt Company Ltd (“The Qt Company”), a wholly owned subsidiary of Qt Group Plc, has announced a public tender offer to the shareholders of I.A.R. Systems Group AB (publ) (“IAR”) to tender all class B shares in IAR to The Qt Company at a price of SEK 180 in cash per share
July 04, 2025

Vinge has advised Consolid on the establishment of Consolid Equity III

The fund held its final closing on June 2, 2025, having secured commitments from a diverse investor base that includes several leading institutional investors from Europe and North America, as well as established fund-of-funds. The fundraising was highly successful, with the fund significantly oversubscribed. Consolid Equity III has more than doubled its total commitments compared to its predecessor fund.
July 02, 2025

Vinge advises EQT VIII in connection with the divestment of Recover to Pangea AS

Recover is a leading Scandinavian property remediation specialist. Following EQT’s acquisition in 2020, Recover has invested in its digital capabilities while divesting non-core business units to sharpen focus on water, fire and other core property remediation services.
July 02, 2025